The liver’s role in metabolic disease
If you’re managing metabolic disease for your patients, you’re also dealing with liver disease, whether you realize it or not. Metabolic dysfunction-associated steatotic liver disease (MASLD) affects up to 70 percent of patients who have type 2 diabetes or obesity, yet reliable, routine screening for liver disease is anything but commonplace.
I often wonder why that is. After all, the liver is arguably the most sensitive barometer of metabolic dysfunction, …
